From: Pancreatectomy for non-pancreatic malignancies results in improved survival after R0 resection
Characteristic | Number (percent) |
---|---|
Total patients | 29 |
Gender | |
Male | 18 (62) |
Female | 11 (38) |
Age | |
Median | 60.0 |
Range | 29–86 |
Operative intent | |
Curative | 22 (76) |
Palliative | 7 (24) |
Indication for pancreatic resection | |
En bloc for direct extension of primary malignancy | 22 (76) |
Metachronous metastasis to pancreas | 7(24) |
Site of primary tumor | |
Colorectal | 9 (31.0) |
Gastric | 8 (27.6) |
Renal cell carcinoma | 5 (17.2) |
Mesenteric fibromatosis | 2 (6.9) |
Hemangiopericytoma (brain) | 1 (3.4) |
Breast | 1 (3.4) |
Esophageal | 1 (3.4) |
Gallbladder | 1 (3.4) |
Chondrosarcoma | 1 (3.4) |
Histologic diagnosis | |
Adenocarcinoma | 19 (65.5) |
Moderately differentiated adenocarcinoma | 10 (34.5) |
Poorly differentiated adenocarcinoma | 5 (17.2) |
Mucinous adenocarcinoma | 1 (3.4) |
Adenocarcinoma not otherwise specified | 3 (10.3) |
Signet ring | 1 (3.4) |
Clear cell | 5 (17.2) |
Mesenteric fibrosis | 2 (6.9) |
Hemangiopericytoma | 1 (3.4) |
Chondrosarcoma | 1 (3.4) |
Extent of pancreatic resection | |
Total pancreatectomy | 1 |
Distal pancreatectomy | 21 |
Pancreaticoduodenectomy | 7 |
Completeness of resection | |
R0 (complete resection) | 17 (59) |
R1 (incomplete resection with microscopic disease) | 4 (14) |
R2 (grossly incomplete resection) | 8 (27) |